Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol

MacDonald, K. N., Ivison, S., Hippen, K. L., Hoeppli, R. E., Hall, M., Zheng, G., Dijke, I. E., Aklabi, M. A., Freed, D. H., Rebeyka, I., Gandhi, S., West, L. J., Piret, J. M., Blazar, B. R., Levings, M. K.  Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol.  Cytotherapy. 2019; 21(12), 1216-1233.  doi: 10.1016/j.jcyt.2019.10.011

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.